Mar 19, 2023 - Dr. David Bearss - Halia Therapeutics

(24:37)

One Utah Summit: Pharmaceutical Innovation \u0026 Manufacturing in N. Utah, Saving \u0026 Improving Lives

(31:55)

David Bearss, CEO, Halia Therapeutics

(5:43)

David Bearss, Halia Therapeutics

(3:52)

2022 BioHive Summit Entrepreneur of the Year Award, Dr. David Bearss, Halia Therapeutics

(3:12)

David Bearss of Halia Therapeutics and Leslie Stolz of J\u0026J at the 2023 Utah Life Sciences Summit

(48:2)

Talking Biotech Podcast - Targeting Chronic Inflammation Via the Inflammasome - Dr. David Bearss

(45:18)

\

(43:19)

Bioworld Insider Podcast Featuring David Bearss of Halia Therapeutics - December 11, 2023

(17:3)

Episode 104: David Bearss: “Gather around. We’re changing the world.”

(46:38)

The Bio Report Podcast - March 2022 - With Dr. David Bearss

(31:46)

Innovation in Higher Education, Perspectives from a Pharma CEO - With Dr. David Bearss of U2TAH T...

(45:27)

Empowering Patient Podcast Featuring Dr. David Bearss - Blocking the Root Cause of Inflammation

(20:12)

Targeting inflammation: A revolution in disease treatment

(43:11)

Life Sciences Executive Roundtable at JPM featuring Dr. David Bearss - Employee Engagement

(43:36)

Halia Therapeutics – Eliminating Chronic Inflammation by Targeting the NLRP3 Inflammasome

(11:8)

Dr. David Bearss, CEO of Halia Therapeutics is recognized as the 2022 Entrepreneur of the Year

(3:12)

Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease

(30:58)

Myeloma Drug Resistance Tied to NEK2 Gene

(52)